B. G., Opalesque Geneva: For several years, investors have pointed out how concentrated the Russell benchmarks have become, according to Kevin Shea, CEO of Disciplined Alpha, a systematic investment manager in Boston. Those concentrations have made it difficult for portfolio managers to create portfolios with reasona...

B. G., Opalesque Geneva: According to Golden Eagle Strategies, a boutique investment firm in the U.S., stocks undergoing hypergrowth produced an annual weighted average return of 37% during 2009-2022, compared to the "rapid growth" stocks' return of 26% and the S&P 500's return of ...

In the week ending June 28th 2024, industry figures showed that emerging markets hedge funds gains accelerated through mid-2Q, leading industry-wide regional performance with contributions across regions as already-elevated geopolitical risk continued to rise, dri...

In the week ending June 28th 2024, industry figures showed that emerging markets hedge funds gains accelerated through mid-2Q, leading industry-wide regional performance with contributions across regions as already-elevated geopolitical risk continued to rise, dri...

B. G., Opalesque Geneva for New Managers: Now is a good time to take advantage of the inefficiencies of the credit market, according to a London-based portfolio manager who is launching a European long/short credit hedge fund. The market opportunity comprises three factors, ...

B. G., Opalesque Geneva: Bob Neighoff, portfolio manager of the Cicero CMBS strategy, a $300m fixed-income strategy focused on seasoned CMBS and CRE (corporate real estate) capital market opportunities, talks to Opalesque about the obscure world of commercial mortgage-backed securities. ...

Reprinted with the permission of the author, Tim Pickering, founder and CIO of Canada-based quantitative investment manager Auspice Capital Advisors Ltd. Like many things within financial markets, the link between commodities and the overall economy and global stock markets is a bit of a mystery. As an example, it is generally understood that centr...

Laxman Pai, Opalesque Asia: The global hedge fund market was valued at $4.8 trillion in 2022 and is estimated to reach $13 trillion by 2032, exhibiting a CAGR of 10.7% from 2023 to 2032, said a study. According to the Allied Market Research report, depending on the strategy, the long/short equity segment held the highest market share in 2022, accounting for more than one-fifth o...

Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 15.40%, according to performance information reviewed by Opalesque....

Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure tops the $3.9bn drawn in by the alternatives manager's inaugural fund in 2021 and...

Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure tops the $3.9bn drawn in by the alternatives manager's inaugural fund in 2021 and...

Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure tops the $3.9bn drawn in by the alternatives manager's inaugural fund in 2021 and...

From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma specialist filed plans to raise $100 million for Helix Acquisition II, its second special purpose...